Konu "Cost–Benefit Analysis" için Tıp Fakültesi listeleme
Toplam kayıt 1, listelenen: 1-1
-
Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis
(SAGE Publications Ltd, 2018)Background: Standard treatment for deep venous thromboembolism involves parenteral anticoagulation overlapping with a vitamin K antagonist, an approach that is effective but associated with limitations including the need ...